SR

Soubhagya Ranjan Behuria

Active Director Director DIN 10579553
DIN 10579553 First appointment Apr 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Soubhagya Ranjan Behuria

Data last updated:

Soubhagya Ranjan Behuria is a Director at Alwyn Laboratories Private Limited (since 2024). The company operates in Healthcare.

DIN 10579553
Primary Designation Director
Industry Healthcare
First Appointment 04 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alwyn Laboratories Private Limited U46497OD2024PTC045481
Director04 Apr 20242024Active

Board colleagues of Soubhagya Ranjan Behuria

NameDINCompanyDesignation
Apali Aparajita Pala10579554Alwyn Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alwyn Laboratories Private Limited
Premium access

Shareholding and investment profile for Soubhagya Ranjan Behuria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Soubhagya Ranjan Behuria

Soubhagya Ranjan Behuria currently holds 1 directorship: Alwyn Laboratories Private Limited (Director, since 04 Apr 2024).

Soubhagya Ranjan Behuria was first appointed on 04 Apr 2024 as Director at Alwyn Laboratories Private Limited.

The current boards of Soubhagya Ranjan Behuria's companies include Apali Aparajita Pala (Alwyn Laboratories Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available